Singapore, March 10 -- As global demand for biologics, advanced therapies, and complex biopharmaceuticals continues to expand, the conversation around competitiveness in biomanufacturing is rapidly shifting. At the APAC Biomanufacturing Leadership Summit 2026 presented by Charles River, industry leaders gathered for a focused panel discussion exploring how Asia Pacific can strengthen its role in the global biomanufacturing ecosystem.

Moderated by Sam Chuang, PhD, Executive Director of Scientific Advisory Services at Charles River, the discussion brought together investors, technology innovators, and manufacturing leaders to examine the strategic, scientific, and operational factors that will define the next phase of global biomanufacturi...